We recently published 10 Big Names Get Slammed. Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is one of the biggest losers on Monday. Arrowhead Pharmaceuticals fell by 12.23 percent on Monday to close at $14.71 apiece as investors turned cautious amid regulatory troubles faced by one of its partners, Sarepta Therapeutics. Last week, the FDA ordered Sarepta Therapeutics to [...]
Arrowhead Pharma (ARWR) Shares Dragged by Sarepta Concerns
